Author, year | Classes of antibiotics | Antibiotics | Percentage used |
---|---|---|---|
Bogale et al. 2019 [25] | Â | Penicillins | 67.2% |
 | Fluoroquinolones | 23% | |
 | Sulphonamides | 40% | |
Erku et al. 2017 [26] | Â | Penicillins | 72% |
 | Tetracyclines | 19% | |
 | Fluoroquinolones | 8.9% | |
Eticha et al. 2014 [27] | Â | Penicillins | 51.7% |
 | Fluoroquinolones | 12.9% | |
 | Tetracyclines | 5.5% | |
Gebeyehu et al. 2015 [28] | Â | Penicillins | 75.5% |
 | Fluoroquinolones | 7.2% | |
 | Tetracyclines | 10.6% | |
Kassa et al. 2022 [30] | Â | Penicillins, | 41.6% |
 | fluoroquinolones, | 40.3% | |
 | Sulphonamides | 8% | |
 | Cephalosporin | 6% | |
 | others | 4% | |
Ayana et al. 2021 [31] | Penicillins | Amoxicillin | 43.6 |
Penicillins | Ampicillin | 11.6 | |
Sulphonamides | Cotrimoxazole | 8.7 | |
Macrolides | azithromycin | 7.6 | |
Penicillins | Cloxacillin | 4.1 | |
Penicillins | Augumentin | 3.5 | |
Cephalosporin | Cefalexin | 2.9 | |
Tetracyclines | Tetracycline | 2.3 | |
Fluoroquinolones | Ciprofloxacin | 1.7 | |
Macrolides | Erythromycin | 1.2 | |
Amphenicols | Chloramphenicol | 1.2 | |
aminoglycosides | Gentamicin | 0.6 | |
Cephalosporin | cefixime | 0.6 | |
Penicillins | Phenoxymethylpenicillin | 0.6 | |
Demissie et al. 2022 [32] | Penicillins | amoxicillin | 22.1% |
Fluoroquinolones | ciprofloxacin | 9.7% | |
Tetracyclines and Fluoroquinolones | doxycycline and ciprofloxacin | 8.7% | |
Sulphonamides | co-trimoxazole | 6.2% | |
Simegn & Moges, 2022 [33] | Penicillins | Amoxicillin | 45% |
Fluoroquinolones | Ciprofloxacin | 36% | |
Penicillins | Amoxicillin with clavulanic acid | 24% | |
Dache et al. 2021 [34] | Penicillins | Amoxicillin | 53.4 |
Tetracyclines | Doxycycline | 5.6 | |
Penicillins | Cloxacillin | 5.2 | |
 | Others | 6 | |
Mossa et al. 2012 [35] | Penicillins | Amoxicillin | 13.5 |
Penicillins | Ampicillin | 5.0 | |
Tetracyclines | Tetracycline | 6.8 | |
Fluoroquinolones | Norfloxacin | 3.3 | |
Fluoroquinolones | Ciprofloxacin | 8.5 | |
Tetracyclines | Doxycycline | 5.0 | |
 | Others | 3.3 |